Table 4.
Combinations of genes predictive for the clinical outcome: gene pairs and gene triplets
Combination | Gene 1 | Gene 2 | Gene 3 | Q (%) | |||
Gene pair | |||||||
1 | TNFAIP3 | 202643_s_at | RAPGEF1 | 204543_at | 90.5 | ||
2 | TNFAIP3 | 202643_s_at | PTPRD | 205712_at | 90.5 | ||
3 | TNFAIP3 | 202644_s_at | PTPRD | 205712_at | 90.5 | ||
4 | IL1B | 205067_at | LGALS13 | 220440_at | 90.5 | ||
5 | CCL4 | 204103_at | ADAM12 | 215613_at | 89.5 | ||
6 | ADAM12 | 215613_at | CCL3 | 205114_s_at | 89.5 | ||
7 | FSD1 | 219170_at | HCG4P6 | 215974_at | 89.5 | ||
Gene triplet | |||||||
1 | CCL4 | 204103_at | PDE4B | 211302_s_at | RAPGEF1 | 204543_at | 99.0 |
2 | PDE4B | 211302_s_at | RAPGEF1 | 204543_at | CXCR4 | 211919_s_at | 98.0 |
3 | CCL4 | 204103_at | PIGO | 214990_at | RAPGEF1 | 204543_at | 96.8 |
4 | CCL4 | 204103_at | FSD1 | 219170_at | RAPGEF1 | 204543_at | 96.8 |
5 | CCL4 | 204103_at | CCL3 | 205114_s_at | RAPGEF1 | 204543_at | 96.8 |
6 | PDE4B | 211302_s_at | RUNX1 | 211620_x_at | RAPGEF1 | 204543_at | 96.8 |
7 | CCL4 | 204103_at | LGALS13 | 220440_at | RAPGEF1 | 204543_at | 95.8 |
8 | TNFAIP3 | 202643_s_at | CCL4 | 204103_at | RAPGEF1 | 204543_at | 95.8 |
9 | TNFAIP3 | 202643_s_at | PDE4B | 211302_s_at | RAPGEF1 | 204543_at | 95.8 |
10 | TNFAIP3 | 202644_s_at | PDE4B | 211302_s_at | RAPGEF1 | 204543_at | 95.8 |
Gene pairs and triplets of genes with prognostic relevance for etanercept therapy in rheumatoid arthritis determined using support vector machines based on 46 selected probe sets of differentially regulated genes. Gene pairs with prediction accuracy Q > 89% and triplets of genes with prediction accuracy Q > 95% are shown. For gene function refer to Table 3.